ISRCTN92184014
Completed
未知
Crossover trial of intranasal oxytocin for treating mother-infant attachment problems in postnatal depression
HS Greater Glasgow & Clyde (UK)0 sites10 target enrollmentMarch 8, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Postnatal mental health / mother-infant attachment
- Sponsor
- HS Greater Glasgow & Clyde (UK)
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Mother with history of low mood (recorded Edinburgh Postnatal Depression Score of ten or greater) with baby aged 8\-16 weeks
- •2\. Mother aged 18 ? 50 years
Exclusion Criteria
- •1\. Baby born before 38 weeks
- •2\. Significant obstetric complications
- •3\. Significant medical condition of mother or baby
- •4\. Substantial neurological or visual impairment of mother or baby
- •5\. Mother non\-English speaking
- •6\. Mother continuing to breast feed
- •7\. Mother has physical condition which might affect nasal drug absorption (eg. URTI)
- •8\. Mother responsible for care of another child at time of home visit
- •9\. Mother pregnant
- •10\. Mothers on antidepressant medication will not be excluded from the study; however we will record if a subject is on medication
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Phase 4
Does intranasal oxytocin enhance emotions in dementia?Alzheimer's diseaseVascular dementiaNeurological - Alzheimer's diseaseNeurological - DementiasACTRN12617001531303niversity of Sydney4
Not yet recruiting
Phase 3
A Clinical trial to study the effects of Intranasal Oxytocin Therapy for Treatmentof Negative Symptoms in SchizophreniaCTRI/2023/12/060817Central Institute of Psychiatry
Not yet recruiting
Phase 2
Oxytocin & benzodiazepines2024-516262-11-00St. Olavs Hospital HF60
Active, not recruiting
Phase 1
Oxytocin intranasal administrations in children with Prader-Willi syndrome aged from 3 to 12 years.EUCTR2016-003273-18-FRniversity Hospital of Toulouse40
Not yet recruiting
Phase 3
Evaluation of the effectiveness of oxytocin by placebo nasal spray on symptoms and treatment of adults with autismAutistic Disorder.Autistic disorderF84.0IRCT20200404046938N1Tehran University of Medical Sciences40